Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Cyanotech Corporation (CYAN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/01/2025: CYAN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -11.28% | Avg. Invested days 23 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.53M USD | Price to earnings Ratio - | 1Y Target Price 14 |
Price to earnings Ratio - | 1Y Target Price 14 | ||
Volume (30-day avg) - | Beta -0.24 | 52 Weeks Range 0.23 - 0.89 | Updated Date 06/29/2025 |
52 Weeks Range 0.23 - 0.89 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.45 |
Earnings Date
Report Date 2025-06-20 | When - | Estimate - | Actual -0.09 |
Profitability
Profit Margin -13.23% | Operating Margin (TTM) -7.18% |
Management Effectiveness
Return on Assets (TTM) -6.16% | Return on Equity (TTM) -30.95% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 14199886 | Price to Sales(TTM) 0.1 |
Enterprise Value 14199886 | Price to Sales(TTM) 0.1 | ||
Enterprise Value to Revenue 0.59 | Enterprise Value to EBITDA 21.94 | Shares Outstanding 7232220 | Shares Floating 4836617 |
Shares Outstanding 7232220 | Shares Floating 4836617 | ||
Percent Insiders 38.34 | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Cyanotech Corporation
Company Overview
History and Background
Cyanotech Corporation, founded in 1983 in Kailua-Kona, Hawaii, focuses on cultivating microalgae for nutritional and health products. It has grown from a research firm to a producer of high-value natural products.
Core Business Areas
- Nutritional Products: Production and sale of dietary supplements derived from microalgae, including spirulina and astaxanthin.
- Animal Nutrition: Provision of microalgae-based ingredients for animal feeds, promoting animal health and well-being.
- Contract Manufacturing: Manufacturing nutritional products for other companies
Leadership and Structure
Gerald R. Cysewski is the Chairman, President and CEO. The company has a standard corporate structure with departments for research, production, sales, and marketing.
Top Products and Market Share
Key Offerings
- BioAstin Hawaiian Astaxanthin: A natural antioxidant supplement. The global astaxanthin market is competitive, with companies like Fuji Chemical Industry and BASF. Market share data for BioAstin is not publicly disclosed but it is a top competitor. Revenue data is also not publicly disclosed. Competitors include Fuji Chemical Industry and BASF
- Nutrex Hawaii Spirulina Pacifica: A blue-green algae supplement known for its nutritional content. The global spirulina market is fragmented. Market share data for Spirulina Pacifica is not publicly disclosed but it is one of the top competitors in the industry. Revenue data is also not publicly disclosed. Competitors include DIC Corporation and Earthrise Nutritionals.
Market Dynamics
Industry Overview
The nutraceuticals industry is growing, driven by increasing consumer awareness of health and wellness, with strong demand for natural and plant-based products.
Positioning
Cyanotech is positioned as a premium supplier of high-quality microalgae-based products, emphasizing its Hawaiian origin and sustainable farming practices.
Total Addressable Market (TAM)
The global nutraceuticals market is estimated at hundreds of billions of dollars, and the astaxanthin and spirulina markets are multi-billion dollar segments. Cyanotech captures a small but significant share of these markets.
Upturn SWOT Analysis
Strengths
- Unique Hawaiian location and brand image
- Sustainable farming practices
- High-quality products
- Established brand recognition
Weaknesses
- Relatively small scale compared to larger competitors
- Vulnerability to weather-related disruptions
- Dependence on specific microalgae species
Opportunities
- Expanding into new markets and product categories
- Increasing consumer demand for natural and sustainable products
- Developing new applications for microalgae
- Strategic partnerships and acquisitions
Threats
- Competition from larger companies
- Price fluctuations in raw materials
- Changes in regulations
- Potential for contamination or quality issues
Competitors and Market Share
Key Competitors
- DIC Corp (6324.T)
- Fuji Chemical Industry (4996.T)
- BASF (BAS.DE)
Competitive Landscape
Cyanotech benefits from its unique location and brand image, but faces competition from larger, more diversified companies with greater resources.
Growth Trajectory and Initiatives
Historical Growth: Cyanotech has experienced steady revenue growth over the past several years, driven by increased demand for its core products.
Future Projections: Without access to analyst estimates, I can not provide projections.
Recent Initiatives: Cyanotech continues to invest in research and development to expand its product portfolio. Further, the company invests in sustainability efforts.
Summary
Cyanotech Corporation is a niche player in the nutraceuticals market, specializing in microalgae-based products. The company benefits from its Hawaiian location and sustainable farming practices, but faces competition from larger companies. Steady growth in revenue and net income indicate solid performance. To maintain its trajectory, Cyanotech needs to carefully navigate price fluctuations and regulatory changes, while continuing to innovate and seek strategic opportunities.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Cyanotech Corporation's website
- Industry reports on nutraceuticals and microalgae
- Financial news sources
Disclaimers:
This analysis is based on publicly available information and does not constitute financial advice. The information is believed to be accurate, but no guarantees are made regarding its completeness or accuracy. Market share data is estimates. Financial data is placeholder and should be replaced with actual values.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cyanotech Corporation
Exchange NASDAQ | Headquaters Kailua-Kona, HI, United States | ||
IPO Launch date 1993-06-22 | President, CEO & Director Mr. Matthew Keith Custer | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 83 | Website https://www.cyanotech.com |
Full time employees 83 | Website https://www.cyanotech.com | ||
Cyanotech Corporation, an agricultural company, engages in the production of natural products derived from microalgae worldwide. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.